微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 19.22% | -22.65% | 17.93% | 45/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 16.3% | -34.48% | -7.76% | 45/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 17.67% | -37.84% | -31.86% | 43/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 25.94% | 2.02% | 4.35% | 41/51 | 38.12% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 24.86% | -31.02% | -0.1% | 43/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 24.88% | -27.87% | -12.49% | 44/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 28.43% | -28.16% | 11.82% | 42/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 25.42% | -19.78% | -29.44% | 44/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 36.03% | 16% | 4.45% | 35/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 34.5% | 19.45% | -12.83% | 39/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 39.57% | 35.3% | 24.88% | 27/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 31.69% | -17.29% | 2.03% | 42/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 31.06% | -13.09% | 7.55% | 33/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 28.88% | -14.38% | -1.26% | 39/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 29.25% | 19.61% | -23.67% | 26/51 | 39.47% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | 38.32% | 0.34% | 7.2% | 33/51 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 35.74% | -6.03% | 5.97% | 26/51 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 33.73% | -10.87% | 37.94% | 28/51 | 39.28% | 南华生物 | 78.74% | 行业排名> |
| 2020-03-31 | 24.45% | -34.92% | -35.96% | 23/51 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 38.18% | -10.85% | 0.39% | 35/51 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 38.03% | -11.4% | 0.5% | 20/51 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 37.84% | -17.91% | 0.72% | 21/51 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 37.57% | -22.25% | -12.28% | 17/51 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 42.83% | -6.11% | -0.22% | 23/51 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 42.93% | -6.37% | -6.88% | 15/51 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 46.1% | -0.19% | -4.6% | 14/51 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 48.32% | 3.67% | 5.93% | 12/51 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 45.62% | -9.69% | -0.5% | 14/51 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 45.85% | -11.15% | -0.74% | 11/51 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 46.19% | -12.77% | -0.91% | 12/51 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 46.61% | -11.53% | -7.72% | 6/51 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 50.51% | 3.14% | -2.11% | 6/51 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 51.6% | 13.26% | -2.55% | 4/51 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 52.95% | 16.78% | 0.5% | 2/51 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 52.68% | 10.96% | 7.58% | 1/51 | 28.42% | 盈康生命 | 75.69% | 行业排名> |
| 2015-12-31 | 48.97% | 2.12% | 7.49% | 6/51 | 37.17% | 海特生物 | 95.38% | 行业排名> |
| 2015-09-30 | 45.56% | -3.28% | 0.48% | 7/51 | 33.25% | 药石科技 | 67.7% | 行业排名> |
| 2015-06-30 | 45.34% | 0.06% | -4.51% | 7/51 | 32.07% | 药石科技 | 66.33% | 行业排名> |
| 2015-03-31 | 47.48% | 12% | -0.99% | 3/51 | 24.2% | 睿智医药 | 52.68% | 行业排名> |